33
/fr/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512555
319423
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Obtenir le Premium
Create a timeline
Public timelines
FAQ
About & FeedbackUn accordConfidentialitéFAQ
Support 24/7  
CabinetGet premium
Donate

1 janv. 2006 - NCI's Study of Tamoxifen and Raloxifene (STAR)

Description:

Results from NCI's Tamoxifen and Raloxifene study show that postmenopausal women at increased risk of breast cancer may reduce their risk of developing the disease if they take raloxifene as an antiestrogen medication. The risk of serious side effects of raloxifene is lower than that of tamoxifen.

Ajouté au bande de temps:

Cancer

ByTrinity Ozias
14 nov. 2019
0
0
302

Date:

1 janv. 2006
Maintenaint
~ Il y a 19 ans
About & FeedbackUn accordConfidentialitéFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL